CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Editas Medicine Inc. (EDIT) on Wednesday reported a loss of $60.7 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 88 cents per share.
The results fell short of Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of 84 cents per share.
The genome editing company posted revenue of $6.5 million in the period, topping Street forecasts. Five analysts surveyed by Zacks expected $4.6 million.
For the year, the company reported that its loss widened to $220.4 million, or $3.21 per share. Revenue was reported as $19.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EDIT at https://www.zacks.com/ap/EDIT
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
